| GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study (NCT00595296) | Janssen Diagnostics, LLC | 2007-12-01 |
| Compliance to a Hormone Therapy Regimen in Breast Cancer (NCT00666822) | Case Comprehensive Cancer Center | 2007-12-01 |
| Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer (NCT00664781) | Cancer Research UK | 2007-12-01 |
| Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer (NCT00570323) | Mothaffar Rimawi | 2007-12-01 |
| Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients (NCT00607295) | Seoul National University Hospital | 2007-12-01 |
| GeneSearch Breast Lymph Node (BLN) Assay Timing Study (NCT00595023) | Janssen Diagnostics, LLC | 2007-12-01 |
| Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer (NCT00503841) | Barbara Ann Karmanos Cancer Institute | 2007-12-01 |
| Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer (NCT01428739) | AHS Cancer Control Alberta | 2007-12-01 |
| AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer (NCT01777932) | Hoffmann-La Roche | 2007-12-01 |
| The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer (NCT00588705) | Memorial Sloan Kettering Cancer Center | 2007-12-01 |
| CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study (NCT00412412) | Biogen | 2007-12-01 |
| Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer (NCT00629278) | Azienda Ospedaliero-Universitaria di Modena | 2007-12-01 |
| The Women's Healthy Lifestyle Study (NCT00583726) | University of Michigan | 2007-12-01 |
| Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 (NCT00659373) | ETOP IBCSG Partners Foundation | 2007-12-01 |
| BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer (NCT00528567) | Hoffmann-La Roche | 2007-12-01 |
| A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. (NCT00559754) | Hoffmann-La Roche | 2007-12-01 |
| A Pilot Study - Comparison of Two Hologic 3D Mammography Systems (NCT00759447) | Hologic, Inc. | 2007-12-01 |
| Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer (NCT01203267) | Shanghai Jiao Tong University School of Medicine | 2007-12-01 |
| Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy (NCT00574587) | Albert Einstein College of Medicine | 2007-12-01 |
| Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients (NCT00772824) | Banaras Hindu University | 2007-12-01 |
| Study of Blood Samples in Patients With Breast Cancer (NCT00959556) | Centre Oscar Lambret | 2007-11-28 |
| Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women (NCT00545077) | Spanish Breast Cancer Research Group | 2007-11-06 |
| Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer (NCT00875355) | Institut Curie | 2007-11-01 |
| Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography (NCT01669148) | Massachusetts General Hospital | 2007-11-01 |
| Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast (NCT00602628) | Royal Marsden NHS Foundation Trust | 2007-11-01 |
| Korean Hereditary Breast Cancer Study (NCT00595348) | Korean Breast Cancer Study Group | 2007-11-01 |
| Local Surgery for Metastatic Breast Cancer (NCT00557986) | Federation of Breast Diseases Societies | 2007-11-01 |
| Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics (NCT00612560) | Roswell Park Cancer Institute | 2007-11-01 |
| Getting Back on Track: An Educational Group for Women With Breast Cancer (NCT01305915) | University Health Network, Toronto | 2007-11-01 |
| Yunzhi as Dietary Supplement in Breast Cancer (NCT00647075) | Hospital Clinic of Barcelona | 2007-11-01 |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer (NCT00898781) | Mayo Clinic | 2007-11-01 |
| A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. (NCT00576901) | Hoffmann-La Roche | 2007-11-01 |
| Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis (NCT00566618) | M.D. Anderson Cancer Center | 2007-11-01 |
| Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer (NCT00536939) | Eli Lilly and Company | 2007-11-01 |
| Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole (NCT00543127) | Spanish Breast Cancer Research Group | 2007-11-01 |
| Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse (NCT00462865) | Brown University | 2007-11-01 |
| MR Characterisation/Localisation of Breast Cancer (NCT01567137) | Institute of Cancer Research, United Kingdom | 2007-11-01 |
| A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy (NCT00555516) | Tri-Service General Hospital (TSGH) | 2007-11-01 |
| Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer (NCT00602316) | Royal Marsden NHS Foundation Trust | 2007-11-01 |
| Multipeptide Vaccine for Advanced Breast Cancer (NCT00573495) | University of Pennsylvania | 2007-11-01 |
| Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer (NCT00548899) | GBG Forschungs GmbH | 2007-11-01 |
| Meditation and Cognitive Function in Women With Breast Cancer (NCT00556218) | M.D. Anderson Cancer Center | 2007-10-24 |
| Cognitive Changes Associated With Breast Cancer Treatment (NCT00550134) | Memorial Sloan Kettering Cancer Center | 2007-10-24 |
| Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer (NCT00530868) | University of Alabama at Birmingham | 2007-10-08 |
| Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer (NCT00873600) | Case Comprehensive Cancer Center | 2007-10-01 |
| Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment (NCT00605267) | AstraZeneca | 2007-10-01 |
| Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses (NCT00536055) | Tel-Aviv Sourasky Medical Center | 2007-10-01 |
| Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00654836) | Loyola University | 2007-10-01 |
| Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer (NCT00957112) | University of Manchester | 2007-10-01 |
| Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer (NCT01985724) | Hellenic Oncology Research Group | 2007-10-01 |
| Human Breast Tissue Bioavailability of Topically Applied Limonene (NCT01459172) | University of Arizona | 2007-10-01 |
| Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy (NCT00681928) | City of Hope Medical Center | 2007-10-01 |
| Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer (NCT00455533) | Bristol-Myers Squibb | 2007-10-01 |
| Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 (NCT00753207) | Cancer Trials Ireland | 2007-10-01 |
| Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer (NCT00629616) | UNICANCER | 2007-10-01 |
| Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer (NCT00546156) | Ian E. Krop, MD, PhD | 2007-10-01 |
| Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients (NCT00882089) | Cancer Center of Irvine | 2007-10-01 |
| A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy (NCT00539227) | M.D. Anderson Cancer Center | 2007-10-01 |
| The Active After Cancer Trial (AACT) (NCT00548236) | Dana-Farber Cancer Institute | 2007-10-01 |
| Telephone-Based Decision Support for Rural Patients (NCT01217333) | University of California, San Francisco | 2007-10-01 |
| Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer (NCT00525161) | Suleiman Massarweh | 2007-10-01 |
| Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer (NCT00542451) | Dana-Farber Cancer Institute | 2007-10-01 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer (NCT00553683) | Rutgers, The State University of New Jersey | 2007-10-01 |
| Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer (NCT00551278) | Janssen Diagnostics, LLC | 2007-10-01 |
| Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial (NCT00666913) | Case Comprehensive Cancer Center | 2007-10-01 |
| Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast (NCT00556907) | University of Southern California | 2007-10-01 |
| Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer (NCT00549822) | Massachusetts General Hospital | 2007-10-01 |
| Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer (NCT00712140) | Warwick Medical School | 2007-10-01 |
| A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer (NCT00540358) | Sanofi | 2007-10-01 |
| Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients (NCT00740532) | Istituto Clinico Humanitas | 2007-10-01 |
| G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer (NCT00771433) | Centre Francois Baclesse | 2007-10-01 |
| Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer (NCT00567554) | GBG Forschungs GmbH | 2007-10-01 |
| Immediate Postmastectomy Breast Reconstruction (Strattice Breast) (NCT00619762) | LifeCell | 2007-10-01 |
| Neuropathic Pain in Survivors of Breast Cancer (NCT00535067) | M.D. Anderson Cancer Center | 2007-09-01 |
| Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years (NCT00563953) | SOLTI Breast Cancer Research Group | 2007-09-01 |
| Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer (NCT00538525) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer (NCT00538330) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Outcomes of a Deep Inferior Epigastric Perforator Flap Program (NCT00543907) | Beth Israel Deaconess Medical Center | 2007-09-01 |
| Liver Safety Under Upfront Arimidex vs Tamoxifen (NCT00537771) | AstraZeneca | 2007-09-01 |
| Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy (NCT00485953) | Susan L. Greenspan | 2007-09-01 |
| Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer (NCT00580333) | Massachusetts General Hospital | 2007-09-01 |
| CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer (NCT00434031) | National Cancer Institute, Naples | 2007-09-01 |
| A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer (NCT00607438) | Veeda Oncology | 2007-09-01 |
| A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy (NCT00644683) | Lynn Henry | 2007-09-01 |
| Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients (NCT00954135) | University of Turin, Italy | 2007-09-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer (NCT00976339) | Katherine D. Crew | 2007-09-01 |
| Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902) (NCT00544505) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer (NCT00537173) | Hoosier Cancer Research Network | 2007-09-01 |
| Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours (NCT00434941) | Spanish Breast Cancer Research Group | 2007-09-01 |
| Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer (NCT00516698) | Alliance for Clinical Trials in Oncology | 2007-09-01 |
| A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial Breast (NCT00529334) | Georgetown University | 2007-09-01 |
| Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer (NCT01172223) | Prof Dirk Elling | 2007-09-01 |
| A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies (NCT00529984) | AlphaVax, Inc. | 2007-09-01 |
| Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer (NCT00538395) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer (NCT00630032) | UNICANCER | 2007-09-01 |
| Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery (NCT00542542) | M.D. Anderson Cancer Center | 2007-09-01 |
| A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin (NCT01152606) | Hoffmann-La Roche | 2007-08-30 |
| Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer (NCT00751101) | University of California, San Francisco | 2007-08-20 |
| Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation (NCT02272400) | NYU Langone Health | 2007-08-07 |